136 related articles for article (PubMed ID: 23359915)
1. Borderline resectable pancreatic cancer: pushing the technical limits of surgery.
Katz MH; Ahmad S; Nelson H
Bull Am Coll Surg; 2013 Jan; 98(1):61-3. PubMed ID: 23359915
[No Abstract] [Full Text] [Related]
2. Defining venous involvement in borderline resectable pancreatic cancer.
Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
[TBL] [Abstract][Full Text] [Related]
3. Borderline resectable pancreatic cancer: More than an anatomical concept.
Petrelli F; Inno A; Barni S; Ghidini A; Labianca R; Falconi M; Reni M; Cascinu S;
Dig Liver Dis; 2017 Feb; 49(2):223-226. PubMed ID: 27931968
[TBL] [Abstract][Full Text] [Related]
4. Management of borderline resectable pancreatic cancer.
Katz MH; Crane CH; Varadhachary G
Semin Radiat Oncol; 2014 Apr; 24(2):105-12. PubMed ID: 24635867
[TBL] [Abstract][Full Text] [Related]
5. Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy.
Evans DB; Erickson BA; Ritch P
Ann Surg Oncol; 2010 Nov; 17(11):2803-5. PubMed ID: 20737218
[No Abstract] [Full Text] [Related]
6. Adjuvant treatments for resectable pancreatic cancer.
Ueno H; Kosuge T
J Hepatobiliary Pancreat Surg; 2008; 15(5):468-72. PubMed ID: 18836798
[TBL] [Abstract][Full Text] [Related]
7. [Borderline resectable pancreatic cancer - a definition and effective treatment strategy].
Yokoyama Y; Ebata T; Igami T; Sugawara G; Takahashi Y; Kokuryo T; Tsunoda N; Fukaya M; Uehara K; Itatsu K; Yoshioka Y; Nagino M
Gan To Kagaku Ryoho; 2012 Mar; 39(3):337-41. PubMed ID: 22421757
[TBL] [Abstract][Full Text] [Related]
8. Treatment for pancreatic cancer.
Held-Warmkessel J; Volpe H; Waldman AR
Clin J Oncol Nurs; 1998 Oct; 2(4):127-34. PubMed ID: 10232158
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant therapy for resectable pancreatic cancer.
Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy.
Barugola G; Partelli S; Crippa S; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Am J Surg; 2012 Feb; 203(2):132-9. PubMed ID: 21824596
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
Zhu AX; Clark JW; Willett CG
Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma.
Artinyan A; Anaya DA; McKenzie S; Ellenhorn JD; Kim J
Cancer; 2011 May; 117(10):2044-9. PubMed ID: 21523715
[TBL] [Abstract][Full Text] [Related]
14. Definition and Management of Borderline Resectable Pancreatic Cancer.
Denbo JW; Fleming JB
Surg Clin North Am; 2016 Dec; 96(6):1337-1350. PubMed ID: 27865281
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of pancreatic cancer.
Büchler MW; Kleeff J; Friess H
J Am Coll Surg; 2007 Oct; 205(4 Suppl):S81-6. PubMed ID: 17916525
[No Abstract] [Full Text] [Related]
16. [Treatment and present status of pancreatic cancer].
Onoyama H; Kamigaki T; Yamamoto M; Saitoh Y
Gan To Kagaku Ryoho; 1992 Dec; 19(14):2304-10. PubMed ID: 1463335
[TBL] [Abstract][Full Text] [Related]
17. Borderline resectable pancreatic cancer-At the crossroads of precision medicine.
Katz MHG; Varadhachary GR
Cancer; 2019 May; 125(10):1584-1587. PubMed ID: 30673119
[No Abstract] [Full Text] [Related]
18. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
[TBL] [Abstract][Full Text] [Related]
19. [Treatment trend for pancreas cancer].
Shimada H
Nihon Geka Gakkai Zasshi; 2006 Jul; 107(4):163. PubMed ID: 16878406
[No Abstract] [Full Text] [Related]
20. What constitutes curative pancreatectomy for adenocarcinoma of the pancreas?
Ishikawa O
Hepatogastroenterology; 1993 Oct; 40(5):414-7. PubMed ID: 8270229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
